Mercado Global de Tratamento da Conjuntivite – Tendências do Setor e Previsão para 2028

Análise e insights de mercado: Mercado global de tratamento da conjuntivite

Espera-se que o mercado de tratamento da conjuntivite ganhe crescimento de mercado no período de previsão de 2021-2028. A Data Bridge Market Research analisa o mercado para crescer a um CAGR de 3,90% no período de previsão acima mencionado e espera atingir os 21,46 mil milhões de dólares até 2028.

A conjuntiva é definida como uma camada de tecido transparente que cobre a superfície interna da pálpebra . Quando a infeção se desenvolve neste tecido, cobre a parte branca do olho e resulta na cor vermelha ou rosa do olho. Por isso, também é chamado de olho rosa. Esta é uma infeção oftálmica que causa inflamação dos olhos e que se chama conjuntivite. As suas causas são classificadas em causas infeciosas e não infeciosas. As bactérias e os vírus estão envolvidos na causa infecciosa e as alérgicas e as inflamações das doenças imunomediadas estão incluídas na causa não infecciosa. Os tipos desta condição dependem da gravidade da doença e incluem conjuntivite aguda, hiperaguda e crónica. Ajuda os profissionais médicos a tomar decisões rápidas sobre o tratamento.

O aumento da prevalência da conjuntivite juntamente com o aparecimento de medicamentos utilizados no tratamento são os principais fatores que influenciam o crescimento do mercado. Além disso, a presença de alergénios externos e internos e a exposição a determinadas toxinas e alterações no ambiente são os fatores que irão expandir o mercado do tratamento da conjuntivite.

Os novos mercados emergentes e os ensaios clínicos em curso proporcionarão oportunidades benéficas para o mercado de tratamento da conjuntivite no período de previsão de 2021-2028.

No entanto, a indisponibilidade e a menor acessibilidade do tratamento eficaz, a expiração das patentes de muitas empresas e a introdução de medicamentos genéricos são os factores que dificultarão o crescimento do mercado. O conhecimento inadequado sobre a doença e o seu tratamento irá desafiar o mercado de tratamento da conjuntivite no período de previsão acima mencionado.

This conjunctivitis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the conjunctivitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Conjunctivitis Treatment Market Scope and Market Size

The conjunctivitis treatment market is segmented on the basis of type, therapy type, drugs, route of administration and end-users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the conjunctivitis treatment market is segmented into allergic conjunctivitis, infectious conjunctivitis and chemical conjunctivitis.
• On the basis of therapy type, the conjunctivitis treatment market is segmented into antibiotic therapy and eye warming therapy.
• On the basis of drugs, the conjunctivitis treatment market is segmented into antibiotics, ophthalmic steroids, non-steroidal anti-inflammatory drugs, antihistamines and others. Antibiotics have been further sub-segmented into gatifloxacin, moxifloxacin, tobramycin and others. Ophthalmic steroids have been further sub-segmented into dexamethasone. Non-steroidal anti-inflammatory drugs have been further sub-segmented into diclofenac. Antihistamines have been further sub-segmented into lodoxamide, olopatadine hydrochloride and cetirizine.
• On the basis of route of administration, the conjunctivitis treatment market is segmented into oral and topical.
• The conjunctivitis treatment market is also segmented on the basis of end-users into hospitals, homecare, specialty clinics and others.

Conjunctivitis Treatment Market Country Level Analysis

Conjunctivitis treatment market is analyzed and market size information is provided by the country, type, therapy type, drugs, route of administration and end-users as referenced above.

The countries covered in the conjunctivitis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the conjunctivitis treatment market due to the presence of major key players, rise in the prevalence of eye disorders and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the surge in the investment for healthcare sector, growing awareness and increase in the disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Conjunctivitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Conjunctivitis Treatment Market Share Analysis

Conjunctivitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to conjunctivitis treatment market research.

Os principais players abordados no relatório de mercado de tratamento da conjuntivite são Allergan, Lupin, Nicox, Eyevance Pharmaceuticals LLC, ALLERGAN, Novartis AG, Aurobindo Pharma, Cipla Inc, Mylan NV, WOCKHARDT, Akron Incorporated, USV Private Limited, Teva Pharmaceutical Industries Ltd , Dr. . Reddy's Laboratories Ltd, Mankind Pharma, Micro Labs Ltd. e Bausch Health Companies Inc., entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-47982